查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1414245

2024年基因轉殖技術全球市場報告

Gene Delivery Technologies Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，基因轉移技術的市場規模迅速擴大。將從2023年的35.7億美元擴大到2024年的41.1億美元，複合年成長率為15.2%。過去觀察到的成長歸因於對遺傳疾病的了解的加深、細胞治療的進步、奈米技術的發展、基因治療試驗的擴大以及研究經費的增加。

遺傳疾病盛行率的上升預計將促進基因轉移技術市場的成長。遺傳性疾病是由個體DNA異常引起的，影響人體發育、功能和維持的指令。基因轉移技術透過引入功能基因、糾正突變和調節基因表現來提供有針對性的治療性介入。根據《衛報》新聞與媒體有限公司 2022 年 8 月報道，預計 2022 年全球將有超過 30 萬名兒童出生時患有鐮狀細胞疾病，約佔全球人口的 50%。因此，遺傳病患病率的增加是推動基因轉殖技術市場成長的關鍵因素。

2023年基因轉殖技術市場最大的地區將是北美。在預測期內，亞太地區預計將成為全球基因轉殖技術市場成長最快的地區。基因轉殖技術市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美以及中東和非洲。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球基因遞送技術市場的驅動與抑制因素
    • 市場促進因素
    • 市場抑制因素
  • 2018-2023年全球基因轉殖技術市場規模表現與成長
  • 全球基因轉殖技術市場規模及成長預測，2023-2028、2033

第6章市場區隔

  • 全球基因轉殖技術市場，依模式、實際及預測細分，2018-2023、2023-2028、2033
  • 生物
  • 科學的
  • 身體的
  • 全球基因轉殖技術市場，依方法、績效及預測細分，2018-2023、2023-2028、2033
  • Ex Vivo
  • In Vivo
  • In Vitro
  • 全球基因轉殖技術市場，依應用、績效與預測細分，2018-2023、2023-2028、2033
  • 基因治療
  • 細胞療法
  • 疫苗
  • 研究

第 7 章 區域與國家分析

  • 全球基因轉殖技術市場，按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球基因轉殖技術市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭形勢及公司概況

  • 基因轉殖技術市場競爭形勢
  • 基因轉移技術市場的公司概況
    • Thermo Fisher Scientific Inc.
    • QIAGEN NV
    • Horizon Discovery Group Co
    • OriGene Technologies Inc.
    • Oxford Biomedica Solutions LLC

第31章競爭基準化分析

第 32 章競爭對手儀表板

第33章 重大併購

第34章 未來前景與潛力分析

第35章附錄

簡介目錄
Product Code: r11755

“Gene Delivery Technologies Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gene delivery technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gene delivery technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The gene delivery technologies market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Mode: Biological; Chemical; Physical
  • 2) By Method: Ex Vivo; In Vivo; In Vitro
  • 3) By Application: Gene Therapy; Cell Therapy; Vaccines; Research
  • Companies Mentioned: Thermo Fisher Scientific Inc.; QIAGEN NV; Horizon Discovery Group Co; OriGene Technologies Inc.; Oxford Biomedica Solutions LLC
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Gene delivery technologies encompass methods utilized to introduce foreign genetic material, such as DNA or RNA, into cells, aiming to transfer the genetic material into the target cells. These technologies are commonly employed in the treatment of diseases or disorders resulting from altered genes, such as mutations or inherited genetic anomalies.

The primary types of gene delivery technologies modes include biological, chemical, and physical approaches. Biological methods involve the use of living organisms or their derivatives in the development and delivery of gene therapy products. Various techniques, such as ex vivo, in vivo, and in vitro applications, are employed in gene therapy, cell therapy, vaccines, and research.

The gene delivery technologies market research report is one of a series of new reports from The Business Research Company that provides gene delivery technologies market statistics, including gene delivery technologies industry global market size, regional shares, competitors with a gene delivery technologies market share, detailed gene delivery technologies market segments, market trends and opportunities, and any further data you may need to thrive in the gene delivery technologies industry. This gene delivery technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gene delivery technologies market size has grown rapidly in recent years. It will grow from $3.57 billion in 2023 to $4.11 billion in 2024 at a compound annual growth rate (CAGR) of 15.2%. The growth observed in the historic period can be attributed to an improved comprehension of genetic diseases, progress in cell therapy, the development of nanotechnology, the expansion of gene therapy trials, and an increase in research funding.

The gene delivery technologies market size is expected to see rapid growth in the next few years. It will grow to $6.96 billion in 2028 at a compound annual growth rate (CAGR) of 14.1%. The anticipated growth in the forecast period can be ascribed to the development of precision medicine, improvements in the regulatory framework, the widespread adoption of gene therapy, and the expansion of non-viral delivery systems. Noteworthy trends expected in the forecast period encompass the application in rare diseases, an increase in clinical trials, the advancement of targeted drug delivery, the expansion of cell therapy, and the development of gene editing tools.

The anticipated growth of the gene delivery technologies market is expected to be propelled by the increasing number of cell and gene therapies. Cell and gene therapies represent medical treatments designed to cure or alleviate diseases by modifying the genetic and cellular makeup of a patient's body. This surge in therapies is driven primarily by advancements in gene editing technologies, playing a crucial role in the development and commercialization of cell and gene therapies. According to an article published by Economist Impact in October 2022, approximately 2,600 clinical trials for CGTs were underway by mid-2021, with researchers estimating 100 approved CGTs in the United States by 2031. The FDA is also projected to approve an average of 8 or 9 CGTs per year between 2022 and 2031, indicating a significant increase in demand for these therapies. Thus, the growing prevalence of cell and gene therapies is a key driver for the gene delivery technologies market.

The rising incidence of genetic disorders is anticipated to contribute to the growth of the gene delivery technologies market. Genetic disorders result from abnormalities in an individual's DNA, affecting the instructions for the development, functioning, and maintenance of the human body. Gene delivery technologies play a crucial role in addressing genetic disorders by introducing functional genes, correcting mutations, and modulating gene expression to provide targeted therapeutic interventions. As reported by Guardian News & Media Limited in August 2022, over 300,000 children worldwide are expected to be born with sickle cell disease in 2022, impacting approximately 5% of the global population. Therefore, the increasing prevalence of genetic disorders is a significant factor driving the growth of the gene delivery technologies market.

Technological advancement has become a prominent trend in the gene delivery technologies market. Major players in the market are directing their efforts toward the development of advanced products to fortify their market positions. For instance, in February 2023, Aera Therapeutics, a US-based biotechnology company, introduced Aera's Platform delivery technology, aiming to unlock the potential of genetic medicines. Aera's PNP technology facilitates precise targeting of RNA molecules implicated in disease processes, enabling the targeted editing of genes in a patient's cells and offering potential for personalized gene therapies.

Leading companies in the gene delivery technologies market are prioritizing technological platforms such as Flowfect Discover's cellular and genome engineering platforms to expedite the development and commercialization of their innovative technologies. Flowfect Discover is a platform revolutionizing cell therapy development by empowering researchers and therapeutic developers to engineer cells with unprecedented precision and efficiency. For example, in May 2021, Kytopen Corp., a US-based biotechnology company, introduced an early access program for its innovative gene delivery platform, Flowfect Discover. This high-throughput gene editing platform utilizes Kytopen's patented electro-mechanical continuous flow technology, featuring attributes such as a closed-system design for enhanced sterility and safety, real-time monitoring and data acquisition for process control, and a user-friendly interface for ease of operation.

In June 2021, PerkinElmer, a US-based company specializing in diagnostics and life sciences, acquired SIRION Biotech for an undisclosed amount. This acquisition aimed to enhance PerkinElmer's capabilities in gene therapy and viral vector technologies, crucial for the development of gene therapies across various diseases. It also bolstered the company's standing as a provider of gene delivery technologies, enabling it to better cater to the growing demand for gene therapies. SIRION Biotech is a German-based provider of viral vector and gene delivery therapy.

Major companies operating in the gene delivery technologies market report are Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

North America was the largest region in the gene delivery technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the gene delivery technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The gene delivery technologies market consists of revenues earned by entities by providing services such as viral vector production, gene editing, gene therapy, and cell therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Gene delivery technologies also include sales of viral and non-viral vectors, transfection reagents, gene editing tools that are used in providing gene delivery. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Gene Delivery Technologies Market Characteristics

3. Gene Delivery Technologies Market Trends And Strategies

4. Gene Delivery Technologies Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Gene Delivery Technologies Market Size and Growth

  • 5.1. Global Gene Delivery Technologies Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Gene Delivery Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Gene Delivery Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gene Delivery Technologies Market Segmentation

  • 6.1. Global Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Biological
  • Chemical
  • Physical
  • 6.2. Global Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Ex Vivo
  • In Vivo
  • In Vitro
  • 6.3. Global Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Gene Therapy
  • Cell Therapy
  • Vaccines
  • Research

7. Gene Delivery Technologies Market Regional And Country Analysis

  • 7.1. Global Gene Delivery Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Gene Delivery Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gene Delivery Technologies Market

  • 8.1. Asia-Pacific Gene Delivery Technologies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gene Delivery Technologies Market

  • 9.1. China Gene Delivery Technologies Market Overview
  • 9.2. China Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gene Delivery Technologies Market

  • 10.1. India Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gene Delivery Technologies Market

  • 11.1. Japan Gene Delivery Technologies Market Overview
  • 11.2. Japan Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gene Delivery Technologies Market

  • 12.1. Australia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gene Delivery Technologies Market

  • 13.1. Indonesia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gene Delivery Technologies Market

  • 14.1. South Korea Gene Delivery Technologies Market Overview
  • 14.2. South Korea Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gene Delivery Technologies Market

  • 15.1. Western Europe Gene Delivery Technologies Market Overview
  • 15.2. Western Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gene Delivery Technologies Market

  • 16.1. UK Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gene Delivery Technologies Market

  • 17.1. Germany Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gene Delivery Technologies Market

  • 18.1. France Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gene Delivery Technologies Market

  • 19.1. Italy Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gene Delivery Technologies Market

  • 20.1. Spain Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gene Delivery Technologies Market

  • 21.1. Eastern Europe Gene Delivery Technologies Market Overview
  • 21.2. Eastern Europe Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gene Delivery Technologies Market

  • 22.1. Russia Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gene Delivery Technologies Market

  • 23.1. North America Gene Delivery Technologies Market Overview
  • 23.2. North America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gene Delivery Technologies Market

  • 24.1. USA Gene Delivery Technologies Market Overview
  • 24.2. USA Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gene Delivery Technologies Market

  • 25.1. Canada Gene Delivery Technologies Market Overview
  • 25.2. Canada Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gene Delivery Technologies Market

  • 26.1. South America Gene Delivery Technologies Market Overview
  • 26.2. South America Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gene Delivery Technologies Market

  • 27.1. Brazil Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gene Delivery Technologies Market

  • 28.1. Middle East Gene Delivery Technologies Market Overview
  • 28.2. Middle East Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gene Delivery Technologies Market

  • 29.1. Africa Gene Delivery Technologies Market Overview
  • 29.2. Africa Gene Delivery Technologies Market, Segmentation By Mode, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Gene Delivery Technologies Market, Segmentation By method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Gene Delivery Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gene Delivery Technologies Market Competitive Landscape And Company Profiles

  • 30.1. Gene Delivery Technologies Market Competitive Landscape
  • 30.2. Gene Delivery Technologies Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. QIAGEN NV
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Horizon Discovery Group Co
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. OriGene Technologies Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Oxford Biomedica Solutions LLC
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Gene Delivery Technologies Market Competitive Benchmarking

32. Global Gene Delivery Technologies Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Gene Delivery Technologies Market

34. Gene Delivery Technologies Market Future Outlook and Potential Analysis

  • 34.1 Gene Delivery Technologies Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Gene Delivery Technologies Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Gene Delivery Technologies Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer